Polymyositis
📧 Sign up to get email alerts when something new happens for Polymyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the efficacy and safety of Efgartigimod PH20 SC in adults with active idiopathic inflammatory myopathy has comp…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) [Phase 2, Phase 3]
A Phase 2/3 clinical trial update reports on safety and efficacy of ULSC for reducing disease severity and enabling steroid tapering in Derm…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies [NA]
A completed clinical trial evaluating the diagnostic accuracy of whole-body magnetic resonance imaging for detecting inflammatory myopathies…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties [NA]
This completed clinical trial evaluated muscle function and the effects of repetitive task training in patients with inflammatory myopathies…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis [Phase 2]
Phase 2 study evaluating an individual rehabilitation program for polymyositis and dermatomyositis has completed and reported efficacy resul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19 [Phase 3]
A Phase 3 study evaluating the efficacy and safety of Longidaza for residual lung changes after COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM) [EARLY_Phase 1]
A Phase 1 study evaluating ULSC in patients with polymyositis and dermatomyositis has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases [Phase 1]
Amgen reported completion of a Phase 1 study of MEDI7734 in Type I interferon-mediated autoimmune diseases, including dermatomyositis, polym…
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM. [Phase 2]
Open-label extension results from the Phase 2 PRESIDIO crossover study evaluating KZR-616 in polymyositis and dermatomyositis have been comp…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments [Phase 3]
Phase 3 trial of ustekinumab in active polymyositis and dermatomyositis was terminated, with results posted on May 13, 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis [Phase 1, Phase 2]
Clinical trial updates on allogeneic mitochondria (PN-101) transplantation for refractory polymyositis or dermatomyositis have completed Pha…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis [Phase 2]
KZR-616, an immunoproteasome inhibitor, was studied in a Phase 2 trial for active polymyositis and dermatomyositis by Kezar Life Sciences; t…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of Froniglutide (PF1801) in patients with idiopathic inflammatory myopathies, in…
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy [Phase 3]
Phase 3 trial evaluating abatacept with standard therapy versus standard therapy alone in adults with active inflammatory myopathy (polymyos…
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Abatacept Treatment in Polymyositis and Dermatomyositis [Phase 2]
Phase 2 trial update evaluating abatacept for polymyositis and dermatomyositis has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis [Phase 2]
Phase 2 clinical trial update for tocilizumab in refractory polymyositis and dermatomyositis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus [Phase 2, Phase 3]
Phase 2/3 trial investigating prednisolone with tacrolimus for myositis-associated pneumonitis has completed; results reported.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis [Phase 2]
Phase 2 trial evaluating infliximab (Remicade) for treatment of dermatomyositis and polymyositis has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis [Phase 2]
Phase 2 trial of BAF312 (likely on symptomatic improvement in polymyositis and dermatomyositis) was terminated with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis [NA]
A clinical trial update evaluating high-intensity interval training as an intervention for recent-onset polymyositis and dermatomyositis. Th…
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: Efficacy and Tolerability of BAF312 in Patients With Polymyositis [Phase 2]
Phase 2 trial evaluating efficacy and tolerability of BAF312 in polymyositis; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Acthar in Treatment of Refractory Dermatomyositis and Polymyositis [Phase 2]
Phase 2 trial of Acthar Gel for refractory dermatomyositis and polymyositis has completed, and the results were posted in August 2017.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM [Phase 3]
A Phase 3 trial comparing methotrexate plus glucocorticoids versus glucocorticoids alone in polymyositis and dermatomyositis; results from t…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) [Phase 2]
Phase 2 trial evaluating rituximab for refractory adult and juvenile dermatomyositis and adult polymyositis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM) [Phase 3]
A Phase 3 trial assessing the efficacy and safety of GB-0998 for steroid-resistant polymyositis and dermatomyositis has completed.